Arete Wealth Advisors, LLC Halozyme Therapeutics, Inc. Transaction History

Arete Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$25.81 - $43.62 $3.88 Million - $6.55 Million	-150,220 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$13.9 - $21.83 $3,058 - $4,802	220 Added 0.15%	150,220 $2.7 Million
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $1.29 Million - $1.69 Million	-86,540 Reduced 36.59%	150,000 $2.66 Million
Q4 2018 Feb 14, 2019	BUY	$13.33 - $18.66 $3.15 Million - $4.41 Million	236,540 New	236,540 $3.46 Million

550

124M

668K

259K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.08B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arete Wealth Advisors, LLC with notifications on news.